Newsroom

CARLSBAD, Calif.--(BUSINESS WIRE)--Ionis Pharmaceuticals, Inc. (Nasdaq: IONS) partner Roche announced today late-breaking oral presentation data from the ongoing Phase 3 IMAgINATION study in adults with primary IgA nephropathy (IgAN) receiving optimized standard of care, demonstrating that investigational sefaxersen achieved a statistically significant and clinically meaningful 43.1% reduction in proteinuria (95% confidence interval [CI]: 32.5 - 52.0, P<0.0001), relative to placebo at 37 wee...

SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)--Genentech, a member of the Roche Group (SIX: RO, ROP; OTCQX: RHHBY), announced today late-breaking oral presentation data from the ongoing Phase III IMAgINATION study in adults with primary IgA nephropathy (IgAN) receiving optimized standard of care, demonstrating that investigational sefaxersen achieved a statistically significant and clinically meaningful 43.1% reduction in proteinuria (95% confidence interval [CI]: 32.5 - 52.0, P<0.0001), relat...

NEW YORK--(BUSINESS WIRE)--Macy’s, Inc. Board of Directors Declares Quarterly Dividend...

GREENVILLE, S.C.--(BUSINESS WIRE)--The Capital Corporation served as the exclusive investment banking advisor to Champion Coach in its partnership with Hoffmann Family of Companies....

HOUSTON--(BUSINESS WIRE)--Building on decades of holding pharmaceutical companies responsible for dangerous products and unlawful business practices, The Lanier Law Firm played a pivotal role supporting Texas Attorney General Ken Paxton in securing a $45 million settlement with Gilead Sciences, Inc. Announced on Oct. 22, the settlement resolves claims that the company offered illegal incentives to medical providers to prescribe its drugs over competitors’ medications. In many cases, these presc...

LOS ANGELES--(BUSINESS WIRE)--Investors in Bank Of America Corporation ("Bank of America" or the "Company") (NYSE: BAC) have until December 15, 2026 to ask the Court to appoint them lead plaintiff in a securities fraud class action lawsuit filed on behalf of investors who purchased or otherwise acquired Bank Of America Corporation securities between August 1, 2025 and October 13, 2026, inclusive. Glancy Prongay Wolke & Rotter LLP ("Glancy") today reminded investors of the upcoming deadline....

WASHINGTON--(BUSINESS WIRE)--Lyntris Inc. (NYSE: LYNX), a defense technology company delivering integrated sensing, communications, and mission systems, today announced it will issue financial results for the third quarter fiscal year 2026 on Wednesday, November 4, 2026. Management will host a conference call and live audio webcast to discuss the results at 4:30 PM Eastern Time. Hosting the call and webcast will be Brian Morrison, CEO; Matt Alty, President and Vice Chair; Tim Paulin, CFO; and N...

SAN DIEGO--(BUSINESS WIRE)--Robbins Geller filed a class action lawsuit alleging that Duolingo and its executives made false and/or misleading statements to investors....

BENSALEM, Pa.--(BUSINESS WIRE)--Millrose Properties, Inc. ("Millrose" or the "Company") (NYSE: MRP) investors who wish to serve as lead plaintiff in a pending securities fraud class action lawsuit must move the Court by December 8, 2026. The suit was filed on behalf of investors who purchased or otherwise acquired the Company's securities from February 7, 2025 through October 2, 2026, inclusive. The Law Offices of Howard G. Smith today highlighted the deadline in the case, Rubenstsein et al. v....

NEW YORK--(BUSINESS WIRE)--KBRA assigns preliminary ratings to 96 classes of mortgage pass-through certificates from Chase Home Lending Mortgage Trust 2026-JINV2 (CHASE 2026-JINV2), a prime investor RMBS transaction comprising 327 residential mortgages with an aggregate interest-bearing principal balance of approximately $398.8 million as of the October 1, 2026 cut-off date. The underlying pool primarily consists of loans that are collateralized by investment properties (94.7%). The pool is cha...